Clemastine Fumarate

富马酸氯马斯汀

Report date: 2026/05/02 20:00:18
NME

Base Information

Drug NameClemastine Fumarate
Drug Alias Name富马酸马斯汀Clemastinum富马酸氯马斯丁clemastina氯马斯丁富马酸盐 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine receptor antagonists
TargetsHistamine receptor
Therapy Area/IndicationsHearingDepressionHypersensitivity +[20] 
Global Approved IndicationsUrticariaPruritusEczema +[5] 
Approved Indications in ChinaUrticariaPruritusEczema +[5] 
Original Approved Country/TerritoryUnited States
Original Approved Date1977/02/25
Country/TerritoryUnited StatesIsraelMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of California San FranciscoTel Aviv UniversityUniversity Of Colorado Denver +[6] 
Inactive CompaniesSandozNovartis Pharma Ag
Active IndicationsHearingDepressionUrticaria +[19] 
Inactive IndicationsHypersensitivity

Other Information

ATC CodeD04AA14R06AA04
Related LinksWikipediaDrugBankKEGG